• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

Listen to the Shorts

They can be wrong, but the skepticism they engender can make us all better investors.
By JIM CRAMER May 08, 2012 | 11:15 AM EDT
Stocks quotes in this article: FOSL, EQIX, MAKO

It's time to praise the short sellers for what they do best.

They lend skepticism to the market. They warn. They give you a head's up even if it means keeping you out of stocks that are momentarily hot or have strong adherents that get too excited and lack discipline.

Today's action in this tumultuous market demonstrates the need to keep track of what short sellers have been saying. Let's tick down the list.

First, there's Fossil (FOSL). There's been no doubt that Fossil's been a rocket ship. It's been an amazing performer over the years. But shorts have repeatedly warned that Fossil's accessory business has always been faddish and would eventually run out of steam, not unlike Deckers (DECK), with its Uggs. Today we found out that Fossil has, indeed, hit a wall, even if it is a European wall. The shorts nailed it.

Second, there's Mako Surgical (MAKO), which has pioneered a robotic system for knee and hip surgery. Here's one that many bulls have tried to analogize to Intuitive Surgical (ISRG). Like Fossil, it's been red hot, but the bears have been wise to it. How do we know? Because almost a third of the float of what trades has been short. This morning, we learned that the string has run out with a huge revenue shortfall. The warnings from the shorts proved true.

Third, there's the curious case of Rackspace (RAX), which as a manager of data warehouses has been trading positively along with all the cloud plays like Equinix (EQIX), F5 (FFIV), Citrix (CTXS) and Salesforce.com (CRM), all of which have turned in some stellar earnings. Herb Greenberg of CNBC has repeatedly warned that Raxspace will eventually be hurt by having to spend too much money on what will amount to a commodity business. Herb's no short seller. He can't trade stocks. But he sorts through a ton of inputs, including those of short sellers and Herb has filtered through the clutter and flagged these warnings. Today Raxspace basically confirmed those worries. It's been hammered.

These stories remind me of Green Mountain Coffee (GMCR), where short sellers very publicly warned of a slowdown, one that's occurred. Today we learned that the chairman of the company sold 5 million shares because of a margin call. He may have been a believer, but the shorts knew better as they often do.

Finally, shorts have repeatedly warned that Dendreon's (DNDN) Provenge, a breakthough prostate cancer treatment, would not be adopted with the alacrity that the incredibly bullish boosters claimed it would. Today the company said growth would be modest and it reported a loss that was larger than people expected.

Now short sellers can be wrong, as wrong as anyone who tries to predict the direction of a stock. They can be early as many of the stocks I have mentioned here were fabulous performers, not unlike Netflix (NFLX), Deckers and Research in Motion (RIMM) before their downfalls. They often target expensive stocks even when there's no flaw and they've been burned for that.   But their function is a good one and the skepticism they engender can make us all better investors.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS,  which Cramer co-manages as a charitable trust, has no positions in the stocks mentioned.

TAGS: Investing | U.S. Equity | Stocks

More from Stocks

5 Factors to Watch in an Oversold Bounce

James "Rev Shark" DePorre
Oct 4, 2023 11:35 AM EDT

If you're stalking a counter-trend upswing in the market, then pay attention to how these scenarios play out.

Apple to the Core: Is It Better to Reduce Than Add Here?

Stephen Guilfoyle
Oct 4, 2023 10:45 AM EDT

The firm's products are profitable, but they are just the key. The key that unlocks much higher margin businesses elsewhere and going forward.

What's Next for Bank of America as the Charts Turn Ugly?

Bruce Kamich
Oct 4, 2023 9:50 AM EDT

Future declines may be likely.

The Uglier Equities and Economic Conditions Get, the More Conservative I Become

Bret Jensen
Oct 4, 2023 9:30 AM EDT

My portfolio definitely isn't sexy as it is focused more on preserving capital than aggressively trying to grow it.

Tom Lee: When a Trade Becomes Obvious, That's Often When the Trend Can Reverse

Tom Lee and the FSI Team
Oct 4, 2023 9:15 AM EDT

Is this becoming a 'single issue' market singularly focused on yields? That will eventually change, but the turning point seems a bit away.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:13 PM EDT BRUCE KAMICH

    8 Trading Rules from T. T. Hoyne

    You just read the header for this missive and prob...
  • 08:42 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How Elite Traders Make Big Profits
  • 02:58 PM EDT BRUCE KAMICH

    Classic Trading Rules From Bernard Baruch

    Bernard Baruch listed the rules (below) in his aut...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login